TapewireFind a company

person · Reporting owner

Radoff Bradley Louis

Disclosed activity across 11 companies

Tapewire entity
26840
SEC CIK
0001380585

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
BARNWELL INDUSTRIES INCBRN · Entity 782310% ownerMarch 28, 2026March 31, 2026
HARTE HANKS INCHHS · Entity 7438DirectorDecember 09, 2025December 11, 2025
KVH INDUSTRIES INC \DE\KVHI · Entity 661210% ownerMay 27, 2026May 30, 2026
Lifevantage CorpLFVN · Entity 6941See Footnote 1August 11, 2023August 15, 2023
REGIONAL HEALTH PROPERTIES, INCRHEP · Entity 834310% ownerApril 13, 2026August 04, 2026
VAALCO ENERGY INC /DE/EGY · Entity 5308DirectorNovember 15, 2021November 18, 2021

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

BARNWELL INDUSTRIES INC

Report date March 28, 2026 · Filed March 31, 2026

Jointly reported with Radoff Family Foundation

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common Stock, $0.50 par valueSEC Table I · non-derivativeDirect560,091 Reported balance Holding disclosure · report date 2026-03-28 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 560,091

F1: This Form 3 is filed jointly by Bradley L. Radoff and The Radoff Family Foundation ("Radoff Foundation" and collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, $0.50 par value. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Common Stock, $0.50 par valueSEC Table I · non-derivativeIndirectBy The Radoff Family Foundation560,090 Reported balance Holding disclosure · report date 2026-03-28 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 560,090

F1: This Form 3 is filed jointly by Bradley L. Radoff and The Radoff Family Foundation ("Radoff Foundation" and collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, $0.50 par value. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation.

Common WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $1.65 · Expires 2029-05-27DirectNot disclosed Reported balance Holding disclosure · report date 2026-03-28 · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · Balance Not disclosed

F1: This Form 3 is filed jointly by Bradley L. Radoff and The Radoff Family Foundation ("Radoff Foundation" and collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, $0.50 par value. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Common WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $1.65 · Expires 2029-05-27IndirectBy The Radoff Family FoundationNot disclosed Reported balance Holding disclosure · report date 2026-03-28 · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · Balance Not disclosed

F1: This Form 3 is filed jointly by Bradley L. Radoff and The Radoff Family Foundation ("Radoff Foundation" and collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, $0.50 par value. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation.

Filing footnotes · ownership attribution and instrument terms

F1: This Form 3 is filed jointly by Bradley L. Radoff and The Radoff Family Foundation ("Radoff Foundation" and collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, $0.50 par value. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation.

HARTE HANKS INC

Report date December 09, 2025 · Filed December 11, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectRSU shares held by Harte Hanks, granted to the participant but not yet vested27,861 Reported balance After 2025-12-09 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 1 · 2025-12-09 · Grant · Acquired 27,861 · Balance 27,861

F1: Participant was granted 27,861 RSU shares on 12/09/2025 that will vest 100% on the first anniversary of the grant date.

Common StockSEC Table I · non-derivativeDirect391,399 Reported balance Holding disclosure · report date 2025-12-09 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 391,399

Common StockSEC Table I · non-derivativeDirect12,048 Reported balance Holding disclosure · report date 2025-12-09 · row 4 Holding and transaction disclosures are not merged.
1 source row

Row 4 · Balance 12,048

F3: Shares vested 100% on 5/23/2025.

Common StockSEC Table I · non-derivativeIndirectCommon stock held in participant's IRA20,000 Reported balance Holding disclosure · report date 2025-12-09 · row 3 Holding and transaction disclosures are not merged.
1 source row

Row 3 · Balance 20,000

F2: Common stock held in participant's IRA

Filing footnotes · ownership attribution and instrument terms

F1: Participant was granted 27,861 RSU shares on 12/09/2025 that will vest 100% on the first anniversary of the grant date.

F2: Common stock held in participant's IRA

F3: Shares vested 100% on 5/23/2025.

KVH INDUSTRIES INC \DE\

Report date May 27, 2026 · Filed May 30, 2026

Jointly reported with Radoff Family Foundation

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectBy The Radoff Family Foundation290,000 Last balance in matching sequence After 2026-05-27 transaction · row 2 Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rows

Row 1 · 2026-05-27 · Sale · Disposed 10,941 · Balance 314,059

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F3: Represents a weighted average price. These Shares were sold in multiple transactions at prices ranging from $10.7600 to $10.9550, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote.

F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.

Row 2 · 2026-05-27 · Sale · Disposed 24,059 · Balance 290,000

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F4: Represents a weighted average price. These Shares were sold in multiple transactions at prices ranging from $10.9600 to $11.9600, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote.

F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.

Common StockSEC Table I · non-derivativeDirect2,180,000 Reported balance Holding disclosure · report date 2026-05-27 · row 3 Holding and transaction disclosures are not merged.
1 source row

Row 3 · Balance 2,180,000

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Filing footnotes · ownership attribution and instrument terms

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.

F3: Represents a weighted average price. These Shares were sold in multiple transactions at prices ranging from $10.7600 to $10.9550, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote.

F4: Represents a weighted average price. These Shares were sold in multiple transactions at prices ranging from $10.9600 to $11.9600, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote.

Lifevantage Corp

Report date August 11, 2023 · Filed August 15, 2023

Jointly reported with Radoff Family Foundation

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectBy The Radoff Family Foundation50,000 Reported balance After 2023-08-11 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 1 · 2023-08-11 · Purchase · Acquired 20,000 · Balance 50,000

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each Reporting Person may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer owned directly by the other members of the Section 13(d) group and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. Further, each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation.

Common StockSEC Table I · non-derivativeDirect811,250 Reported balance Holding disclosure · report date 2023-08-11 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 811,250

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each Reporting Person may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer owned directly by the other members of the Section 13(d) group and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. Further, each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each Reporting Person may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer owned directly by the other members of the Section 13(d) group and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. Further, each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation.

REGIONAL HEALTH PROPERTIES, INC

Report date April 13, 2026 · Filed August 04, 2026

Jointly reported with Radoff Family Foundation

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect220,737 Last balance in matching sequence After 2026-04-22 transaction · row 3 Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rows

Row 1 · 2026-04-13 · Purchase · Acquired 6,300 · Balance 215,226

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Row 2 · 2026-04-14 · Purchase · Acquired 3,511 · Balance 218,737

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Row 3 · 2026-04-22 · Purchase · Acquired 2,000 · Balance 220,737

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Common StockSEC Table I · non-derivativeIndirectBy The Radoff Family Foundation105,900 Last balance in matching sequence After 2026-06-15 transaction · row 9 Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
6 source rows

Row 4 · 2026-04-13 · Purchase · Acquired 100 · Balance 108,491

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.

Row 5 · 2026-04-22 · Purchase · Acquired 500 · Balance 108,991

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.

Row 6 · 2026-04-27 · Purchase · Acquired 1,000 · Balance 109,991

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.

Row 7 · 2026-04-29 · Purchase · Acquired 1,009 · Balance 111,000

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.

Row 8 · 2026-06-05 · Sale · Disposed 5,000 · Balance 106,000

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.

Row 9 · 2026-06-15 · Sale · Disposed 100 · Balance 105,900

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.

Series D Preferred StockSEC Table II · derivative / convertible securityDirect170,263 Reported balance After 2026-04-14 transaction · row 10 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 10 · 2026-04-14 · Purchase · Acquired 600 · Balance 170,263

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F3: The Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares (the "Series D Preferred Stock") is convertible at any time at the option of the holder into a number of shares of Common Stock at a conversion ratio equal to 1.1330 shares of Common Stock for every three shares of Series D Preferred Stock, subject to adjustment as provided in the Issuer's articles of amendment. Under the Issuer's articles of amendment, the Series D Preferred Stock may not be converted if, after such conversion, the Reporting Persons would beneficially own, as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock pursuant to such conversion. The Series D Preferred Stock has no expiration date.

Series D Preferred StockSEC Table II · derivative / convertible securityDirect171,263 Reported balance After 2026-04-15 transaction · row 11 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 11 · 2026-04-15 · Purchase · Acquired 1,000 · Balance 171,263

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F3: The Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares (the "Series D Preferred Stock") is convertible at any time at the option of the holder into a number of shares of Common Stock at a conversion ratio equal to 1.1330 shares of Common Stock for every three shares of Series D Preferred Stock, subject to adjustment as provided in the Issuer's articles of amendment. Under the Issuer's articles of amendment, the Series D Preferred Stock may not be converted if, after such conversion, the Reporting Persons would beneficially own, as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock pursuant to such conversion. The Series D Preferred Stock has no expiration date.

Filing footnotes · ownership attribution and instrument terms

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.

F3: The Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares (the "Series D Preferred Stock") is convertible at any time at the option of the holder into a number of shares of Common Stock at a conversion ratio equal to 1.1330 shares of Common Stock for every three shares of Series D Preferred Stock, subject to adjustment as provided in the Issuer's articles of amendment. Under the Issuer's articles of amendment, the Series D Preferred Stock may not be converted if, after such conversion, the Reporting Persons would beneficially own, as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock pursuant to such conversion. The Series D Preferred Stock has no expiration date.

VAALCO ENERGY INC /DE/

Report date November 15, 2021 · Filed November 18, 2021

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common stockSEC Table I · non-derivativeDirect1,154,976 Ending reported balance After 2021-11-17 transaction · row 3
3 source rows · reconciled sequence

Row 1 · 2021-11-15 · Sale · Disposed 39,437 · Balance 1,315,539

Row 2 · 2021-11-16 · Sale · Disposed 60,563 · Balance 1,254,976

Row 3 · 2021-11-17 · Sale · Disposed 100,000 · Balance 1,154,976

Common StockSEC Table I · non-derivativeIndirectRadoff Family Foundation85,000 Reported balance Holding disclosure · report date 2021-11-15 · row 4 Holding and transaction disclosures are not merged.
1 source row

Row 4 · Balance 85,000

F1: Shares of common stock beneficially owned directly by the Radoff Foundation. As a director of the Radoff Foundation, Mr. Radoff may be deemed to beneficially own the shares of common stock beneficially owned by the Radoff Foundation.

Filing footnotes · ownership attribution and instrument terms

F1: Shares of common stock beneficially owned directly by the Radoff Foundation. As a director of the Radoff Foundation, Mr. Radoff may be deemed to beneficially own the shares of common stock beneficially owned by the Radoff Foundation.

Past disclosures · reporting ended (5)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

ENZO BIOCHEM INC

Report date August 20, 2025 · Filed August 20, 2025

Section 16 reporting ended · disclosed 2025-08-20. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect0 Reported balance After 2025-08-20 transaction · row 1
1 source row

Row 1 · 2025-08-20 · Disposition to issuer · Disposed 4,533,779 · Balance 0

F1: The shares were disposed of pursuant to the Agreement and Plan of Merger, dated June 23, 2025 (the "Merger Agreement"), by and among the Issuer, Bethpage Parent, Inc. ("Parent"), and Bethpage Merger Sub, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"). Pursuant to the terms of the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly-owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of the Issuer's common stock, par value $0.01 per share ("Common Stock"), was canceled and automatically converted into the right to receive $0.70 in cash, without interest and less any applicable withholding taxes (the "Merger Consideration").

F2: Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit ("RSU") that vested solely on the basis of time that was outstanding as of immediately prior to the Effective Time and was held by a member of the Issuer's Board of Directors was canceled and converted into the right to receive an amount in cash obtained by multiplying (A) the total number of shares of Common Stock underlying such RSU, by (B) the Merger Consideration, subject to any required withholding of taxes.

F3: Represents 142,897 RSUs and 4,390,882 shares of Common Stock.

Common StockSEC Table I · non-derivativeIndirectBy The Radoff Family Foundation0 Reported balance After 2025-08-20 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 2 · 2025-08-20 · Disposition to issuer · Disposed 430,000 · Balance 0

F1: The shares were disposed of pursuant to the Agreement and Plan of Merger, dated June 23, 2025 (the "Merger Agreement"), by and among the Issuer, Bethpage Parent, Inc. ("Parent"), and Bethpage Merger Sub, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"). Pursuant to the terms of the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly-owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of the Issuer's common stock, par value $0.01 per share ("Common Stock"), was canceled and automatically converted into the right to receive $0.70 in cash, without interest and less any applicable withholding taxes (the "Merger Consideration").

Filing footnotes · ownership attribution and instrument terms

F1: The shares were disposed of pursuant to the Agreement and Plan of Merger, dated June 23, 2025 (the "Merger Agreement"), by and among the Issuer, Bethpage Parent, Inc. ("Parent"), and Bethpage Merger Sub, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"). Pursuant to the terms of the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly-owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of the Issuer's common stock, par value $0.01 per share ("Common Stock"), was canceled and automatically converted into the right to receive $0.70 in cash, without interest and less any applicable withholding taxes (the "Merger Consideration").

F2: Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit ("RSU") that vested solely on the basis of time that was outstanding as of immediately prior to the Effective Time and was held by a member of the Issuer's Board of Directors was canceled and converted into the right to receive an amount in cash obtained by multiplying (A) the total number of shares of Common Stock underlying such RSU, by (B) the Merger Consideration, subject to any required withholding of taxes.

F3: Represents 142,897 RSUs and 4,390,882 shares of Common Stock.

FARMER BROTHERS CO

Report date May 05, 2026 · Filed May 05, 2026

Section 16 reporting ended · disclosed 2026-05-05. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect0 Reported balance After 2026-05-05 transaction · row 1
1 source row

Row 1 · 2026-05-05 · Disposition to issuer · Disposed 368,679 · Balance 0

F1: Pursuant to the Agreement and Plan of Merger, dated March 3, 2026, by and among the Issuer, Royal Cup, Inc. ("Parent") and BP I Brew Merger Sub Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Parent (the "Merger"). At the effective time of the Merger (the "Effective Time"), upon the terms and subject to the conditions set forth in the Merger Agreement, each share of the Issuer's common stock, par value $1.00 per share ("Common Stock"), that was issued and outstanding immediately prior to the Effective Time was automatically cancelled and converted into the right to receive $1.29 per share of Common Stock in cash, without interest. The disposition of the securities by the Reporting Person in the Merger was approved by the Company's board of directors in the manner contemplated by Rule 16b-3 under the Securities Exchange Act of 1934, as amended.

Common StockSEC Table I · non-derivativeIndirectBy the Radoff Family Foundation0 Reported balance After 2026-05-05 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 2 · 2026-05-05 · Disposition to issuer · Disposed 125,000 · Balance 0

F1: Pursuant to the Agreement and Plan of Merger, dated March 3, 2026, by and among the Issuer, Royal Cup, Inc. ("Parent") and BP I Brew Merger Sub Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Parent (the "Merger"). At the effective time of the Merger (the "Effective Time"), upon the terms and subject to the conditions set forth in the Merger Agreement, each share of the Issuer's common stock, par value $1.00 per share ("Common Stock"), that was issued and outstanding immediately prior to the Effective Time was automatically cancelled and converted into the right to receive $1.29 per share of Common Stock in cash, without interest. The disposition of the securities by the Reporting Person in the Merger was approved by the Company's board of directors in the manner contemplated by Rule 16b-3 under the Securities Exchange Act of 1934, as amended.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the Agreement and Plan of Merger, dated March 3, 2026, by and among the Issuer, Royal Cup, Inc. ("Parent") and BP I Brew Merger Sub Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Parent (the "Merger"). At the effective time of the Merger (the "Effective Time"), upon the terms and subject to the conditions set forth in the Merger Agreement, each share of the Issuer's common stock, par value $1.00 per share ("Common Stock"), that was issued and outstanding immediately prior to the Effective Time was automatically cancelled and converted into the right to receive $1.29 per share of Common Stock in cash, without interest. The disposition of the securities by the Reporting Person in the Merger was approved by the Company's board of directors in the manner contemplated by Rule 16b-3 under the Securities Exchange Act of 1934, as amended.

Guardion Health Sciences, Inc.

Report date August 26, 2024 · Filed August 28, 2024

Jointly reported with Radoff Family Foundation

Section 16 reporting ended · disclosed 2024-08-28. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect112,414 Last balance in matching sequence After 2024-08-26 transaction · row 3 Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rows

Row 1 · 2024-08-26 · Sale · Disposed 52,686 · Balance 165,214

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons was deemed to be a member of a Section 13(d) group that was previously deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose.

F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.05 to $13.85 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Row 2 · 2024-08-26 · Sale · Disposed 44,550 · Balance 120,664

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons was deemed to be a member of a Section 13(d) group that was previously deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose.

F3: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.19 to $15.01 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Row 3 · 2024-08-26 · Sale · Disposed 8,250 · Balance 112,414

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons was deemed to be a member of a Section 13(d) group that was previously deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose.

Common StockSEC Table I · non-derivativeIndirectBy The Radoff Family Foundation15,046 Reported balance After 2024-08-26 transaction · row 4 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 4 · 2024-08-26 · Sale · Disposed 10,054 · Balance 15,046

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons was deemed to be a member of a Section 13(d) group that was previously deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose.

F4: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.39 to $14.38 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation.

Filing footnotes · ownership attribution and instrument terms

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons was deemed to be a member of a Section 13(d) group that was previously deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose.

F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.05 to $13.85 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.19 to $15.01 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.39 to $14.38 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation.

Rocky Mountain Chocolate Factory, Inc.

Report date October 23, 2024 · Filed October 25, 2024

Jointly reported with Radoff Family Foundation

Section 16 reporting ended · disclosed 2024-10-25. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common Stock, $0.001 par value per shareSEC Table I · non-derivativeDirect450,148 Reported balance After 2024-10-23 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 1 · 2024-10-23 · Sale · Disposed 12,400 · Balance 450,148

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons is a member of a Section 13(d) group that previously collectively beneficially owned more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Common Stock, $0.001 par value per shareSEC Table I · non-derivativeIndirectBy The Radoff Family Foundation299,817 Reported balance Holding disclosure · report date 2024-10-23 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 299,817

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons is a member of a Section 13(d) group that previously collectively beneficially owned more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation.

Filing footnotes · ownership attribution and instrument terms

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons is a member of a Section 13(d) group that previously collectively beneficially owned more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation.

Support.com, Inc.

Report date September 14, 2021 · Filed September 15, 2021

Section 16 reporting ended · disclosed 2021-09-15. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect0 Reported balance After 2021-09-14 transaction · row 1
1 source row

Row 1 · 2021-09-14 · Disposition to issuer · Disposed 435,536 · Balance 0

F1: Support.com, Inc., a Delaware corporation (the "Company"), entered into an Agreement and Plan of Merger (the "Merger Agreement"), dated as of March 19, 2021, by and among the Company, Greenidge Generation Holdings Inc., a Delaware corporation ("Greenidge") and GGH Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Greenidge ("Merger Sub"). On September 14, 2021, Merger Sub merged with and into the Company, the separate corporate existence of Merger Sub ceased and the Company survived the merger as a direct wholly owned subsidiary of Greenidge.

F2: (Continued form Footnote 1) Pursuant to the terms of the Merger Agreement, each share of common stock, par value $0.0001 per share, of the Company (the "Common Stock") and each restricted stock unit of the Company that was outstanding as of the closing of the merger (the "Closing") was converted into the right to receive 0.115 shares of class A common stock, par value $0.0001 per share, of Greenidge (the "Greenidge Class A Common Stock") (the "Exchange Ratio").

F3: Represents 410,156 shares of Common Stock and 25,380 restricted stock units held by the Reporting Person.

Common StockSEC Table I · non-derivativeIndirectBy BLR Partners, LP0 Reported balance After 2021-09-14 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 2 · 2021-09-14 · Disposition to issuer · Disposed 1,301,874 · Balance 0

F1: Support.com, Inc., a Delaware corporation (the "Company"), entered into an Agreement and Plan of Merger (the "Merger Agreement"), dated as of March 19, 2021, by and among the Company, Greenidge Generation Holdings Inc., a Delaware corporation ("Greenidge") and GGH Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Greenidge ("Merger Sub"). On September 14, 2021, Merger Sub merged with and into the Company, the separate corporate existence of Merger Sub ceased and the Company survived the merger as a direct wholly owned subsidiary of Greenidge.

F2: (Continued form Footnote 1) Pursuant to the terms of the Merger Agreement, each share of common stock, par value $0.0001 per share, of the Company (the "Common Stock") and each restricted stock unit of the Company that was outstanding as of the closing of the merger (the "Closing") was converted into the right to receive 0.115 shares of class A common stock, par value $0.0001 per share, of Greenidge (the "Greenidge Class A Common Stock") (the "Exchange Ratio").

Filing footnotes · ownership attribution and instrument terms

F1: Support.com, Inc., a Delaware corporation (the "Company"), entered into an Agreement and Plan of Merger (the "Merger Agreement"), dated as of March 19, 2021, by and among the Company, Greenidge Generation Holdings Inc., a Delaware corporation ("Greenidge") and GGH Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Greenidge ("Merger Sub"). On September 14, 2021, Merger Sub merged with and into the Company, the separate corporate existence of Merger Sub ceased and the Company survived the merger as a direct wholly owned subsidiary of Greenidge.

F2: (Continued form Footnote 1) Pursuant to the terms of the Merger Agreement, each share of common stock, par value $0.0001 per share, of the Company (the "Common Stock") and each restricted stock unit of the Company that was outstanding as of the closing of the merger (the "Closing") was converted into the right to receive 0.115 shares of class A common stock, par value $0.0001 per share, of Greenidge (the "Greenidge Class A Common Stock") (the "Exchange Ratio").

F3: Represents 410,156 shares of Common Stock and 25,380 restricted stock units held by the Reporting Person.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 15, 2026 Filed Aug 4, 2026 21:14 UTC REGIONAL HEALTH PROPERTIES, INC RHEP · Entity 8343 SaleCommon Stock 100 $1.06 $106.00
Disclosure

SEC source: 0000921895-26-001950 · form409076039_08042026.xml · nonDerivative · entry 9

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Radoff Family Foundation

Disclosed balance after: 105,900

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2 · ownership.nature: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.

Read SEC document
June 05, 2026 Filed Aug 4, 2026 21:14 UTC REGIONAL HEALTH PROPERTIES, INC RHEP · Entity 8343 SaleCommon Stock 5,000 $1.15 $5,750.00
Disclosure

SEC source: 0000921895-26-001950 · form409076039_08042026.xml · nonDerivative · entry 8

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Radoff Family Foundation

Disclosed balance after: 106,000

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2 · ownership.nature: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.

Read SEC document
May 27, 2026 Filed May 30, 2026 00:30 UTC KVH INDUSTRIES INC \DE\ KVHI · Entity 6612 SaleCommon Stock 24,059 $11.39 $274,094.56
Disclosure

SEC source: 0000921895-26-001507 · form409076051_05292026.xml · nonDerivative · entry 2

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Radoff Family Foundation

Disclosed balance after: 290,000

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F4 · price: Represents a weighted average price. These Shares were sold in multiple transactions at prices ranging from $10.9600 to $11.9600, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.

Read SEC document
May 27, 2026 Filed May 30, 2026 00:30 UTC KVH INDUSTRIES INC \DE\ KVHI · Entity 6612 SaleCommon Stock 10,941 $10.78 $117,899.12
Disclosure

SEC source: 0000921895-26-001507 · form409076051_05292026.xml · nonDerivative · entry 1

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Radoff Family Foundation

Disclosed balance after: 314,059

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F3 · price: Represents a weighted average price. These Shares were sold in multiple transactions at prices ranging from $10.7600 to $10.9550, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.

Read SEC document
May 05, 2026 Filed May 5, 2026 19:51 UTC FARMER BROTHERS CO FARM · Entity 49843 Disposition to issuerCommon Stock 125,000 $1.29 $161,250.00
Disclosure

SEC source: 0001380585-26-000002 · wk-form4_1778010684.xml · nonDerivative · entry 2

Radoff Bradley Louis · CIK 0001380585 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By the Radoff Family Foundation

Disclosed balance after: 0

F1 · kind: Pursuant to the Agreement and Plan of Merger, dated March 3, 2026, by and among the Issuer, Royal Cup, Inc. ("Parent") and BP I Brew Merger Sub Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Parent (the "Merger"). At the effective time of the Merger (the "Effective Time"), upon the terms and subject to the conditions set forth in the Merger Agreement, each share of the Issuer's common stock, par value $1.00 per share ("Common Stock"), that was issued and outstanding immediately prior to the Effective Time was automatically cancelled and converted into the right to receive $1.29 per share of Common Stock in cash, without interest. The disposition of the securities by the Reporting Person in the Merger was approved by the Company's board of directors in the manner contemplated by Rule 16b-3 under the Securities Exchange Act of 1934, as amended.

Read SEC document
May 05, 2026 Filed May 5, 2026 19:51 UTC FARMER BROTHERS CO FARM · Entity 49843 Disposition to issuerCommon Stock 368,679 $1.29 $475,595.91
Disclosure

SEC source: 0001380585-26-000002 · wk-form4_1778010684.xml · nonDerivative · entry 1

Radoff Bradley Louis · CIK 0001380585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · kind: Pursuant to the Agreement and Plan of Merger, dated March 3, 2026, by and among the Issuer, Royal Cup, Inc. ("Parent") and BP I Brew Merger Sub Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Parent (the "Merger"). At the effective time of the Merger (the "Effective Time"), upon the terms and subject to the conditions set forth in the Merger Agreement, each share of the Issuer's common stock, par value $1.00 per share ("Common Stock"), that was issued and outstanding immediately prior to the Effective Time was automatically cancelled and converted into the right to receive $1.29 per share of Common Stock in cash, without interest. The disposition of the securities by the Reporting Person in the Merger was approved by the Company's board of directors in the manner contemplated by Rule 16b-3 under the Securities Exchange Act of 1934, as amended.

Read SEC document
April 29, 2026 Filed Aug 4, 2026 21:14 UTC REGIONAL HEALTH PROPERTIES, INC RHEP · Entity 8343 PurchaseCommon Stock 1,009 $1.42 $1,436.92
Disclosure

SEC source: 0000921895-26-001950 · form409076039_08042026.xml · nonDerivative · entry 7

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Radoff Family Foundation

Disclosed balance after: 111,000

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2 · ownership.nature: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.

Read SEC document
April 27, 2026 Filed Aug 4, 2026 21:14 UTC REGIONAL HEALTH PROPERTIES, INC RHEP · Entity 8343 PurchaseCommon Stock 1,000 $1.40 $1,400.00
Disclosure

SEC source: 0000921895-26-001950 · form409076039_08042026.xml · nonDerivative · entry 6

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Radoff Family Foundation

Disclosed balance after: 109,991

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2 · ownership.nature: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.

Read SEC document
April 22, 2026 Filed Aug 4, 2026 21:14 UTC REGIONAL HEALTH PROPERTIES, INC RHEP · Entity 8343 PurchaseCommon Stock 500 $1.40 $700.00
Disclosure

SEC source: 0000921895-26-001950 · form409076039_08042026.xml · nonDerivative · entry 5

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Radoff Family Foundation

Disclosed balance after: 108,991

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2 · ownership.nature: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.

Read SEC document
April 22, 2026 Filed Aug 4, 2026 21:14 UTC REGIONAL HEALTH PROPERTIES, INC RHEP · Entity 8343 PurchaseCommon Stock 2,000 $1.43 $2,860.00
Disclosure

SEC source: 0000921895-26-001950 · form409076039_08042026.xml · nonDerivative · entry 3

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 220,737

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Read SEC document
April 15, 2026 Filed Aug 4, 2026 21:14 UTC REGIONAL HEALTH PROPERTIES, INC RHEP · Entity 8343 PurchaseSeries D Preferred Stock · Derivative 1,000 $2.20 $2,200.90
Disclosure

SEC source: 0000921895-26-001950 · form409076039_08042026.xml · derivative · entry 11

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 171,263

Underlying: Common Stock · 377 shares

Expires not disclosed

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F3 · derivative.exercise_price: The Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares (the "Series D Preferred Stock") is convertible at any time at the option of the holder into a number of shares of Common Stock at a conversion ratio equal to 1.1330 shares of Common Stock for every three shares of Series D Preferred Stock, subject to adjustment as provided in the Issuer's articles of amendment. Under the Issuer's articles of amendment, the Series D Preferred Stock may not be converted if, after such conversion, the Reporting Persons would beneficially own, as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock pursuant to such conversion. The Series D Preferred Stock has no expiration date.

F3 · derivative.exercise_date: The Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares (the "Series D Preferred Stock") is convertible at any time at the option of the holder into a number of shares of Common Stock at a conversion ratio equal to 1.1330 shares of Common Stock for every three shares of Series D Preferred Stock, subject to adjustment as provided in the Issuer's articles of amendment. Under the Issuer's articles of amendment, the Series D Preferred Stock may not be converted if, after such conversion, the Reporting Persons would beneficially own, as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock pursuant to such conversion. The Series D Preferred Stock has no expiration date.

F3 · derivative.expiration_date: The Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares (the "Series D Preferred Stock") is convertible at any time at the option of the holder into a number of shares of Common Stock at a conversion ratio equal to 1.1330 shares of Common Stock for every three shares of Series D Preferred Stock, subject to adjustment as provided in the Issuer's articles of amendment. Under the Issuer's articles of amendment, the Series D Preferred Stock may not be converted if, after such conversion, the Reporting Persons would beneficially own, as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock pursuant to such conversion. The Series D Preferred Stock has no expiration date.

Read SEC document
April 14, 2026 Filed Aug 4, 2026 21:14 UTC REGIONAL HEALTH PROPERTIES, INC RHEP · Entity 8343 PurchaseSeries D Preferred Stock · Derivative 600 $2.13 $1,277.46
Disclosure

SEC source: 0000921895-26-001950 · form409076039_08042026.xml · derivative · entry 10

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 170,263

Underlying: Common Stock · 226 shares

Expires not disclosed

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F3 · derivative.exercise_price: The Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares (the "Series D Preferred Stock") is convertible at any time at the option of the holder into a number of shares of Common Stock at a conversion ratio equal to 1.1330 shares of Common Stock for every three shares of Series D Preferred Stock, subject to adjustment as provided in the Issuer's articles of amendment. Under the Issuer's articles of amendment, the Series D Preferred Stock may not be converted if, after such conversion, the Reporting Persons would beneficially own, as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock pursuant to such conversion. The Series D Preferred Stock has no expiration date.

F3 · derivative.exercise_date: The Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares (the "Series D Preferred Stock") is convertible at any time at the option of the holder into a number of shares of Common Stock at a conversion ratio equal to 1.1330 shares of Common Stock for every three shares of Series D Preferred Stock, subject to adjustment as provided in the Issuer's articles of amendment. Under the Issuer's articles of amendment, the Series D Preferred Stock may not be converted if, after such conversion, the Reporting Persons would beneficially own, as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock pursuant to such conversion. The Series D Preferred Stock has no expiration date.

F3 · derivative.expiration_date: The Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares (the "Series D Preferred Stock") is convertible at any time at the option of the holder into a number of shares of Common Stock at a conversion ratio equal to 1.1330 shares of Common Stock for every three shares of Series D Preferred Stock, subject to adjustment as provided in the Issuer's articles of amendment. Under the Issuer's articles of amendment, the Series D Preferred Stock may not be converted if, after such conversion, the Reporting Persons would beneficially own, as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock pursuant to such conversion. The Series D Preferred Stock has no expiration date.

Read SEC document
April 14, 2026 Filed Aug 4, 2026 21:14 UTC REGIONAL HEALTH PROPERTIES, INC RHEP · Entity 8343 PurchaseCommon Stock 3,511 $1.30 $4,553.42
Disclosure

SEC source: 0000921895-26-001950 · form409076039_08042026.xml · nonDerivative · entry 2

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 218,737

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Read SEC document
April 13, 2026 Filed Aug 4, 2026 21:14 UTC REGIONAL HEALTH PROPERTIES, INC RHEP · Entity 8343 PurchaseCommon Stock 100 $1.21 $121.00
Disclosure

SEC source: 0000921895-26-001950 · form409076039_08042026.xml · nonDerivative · entry 4

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Radoff Family Foundation

Disclosed balance after: 108,491

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2 · ownership.nature: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.

Read SEC document
April 13, 2026 Filed Aug 4, 2026 21:14 UTC REGIONAL HEALTH PROPERTIES, INC RHEP · Entity 8343 PurchaseCommon Stock 6,300 $1.29 $8,124.48
Disclosure

SEC source: 0000921895-26-001950 · form409076039_08042026.xml · nonDerivative · entry 1

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 215,226

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Read SEC document
February 12, 2026 Filed Feb 12, 2026 22:56 UTC KVH INDUSTRIES INC \DE\ KVHI · Entity 6612 PurchaseCommon Stock 30,000 $6.26 $187,944.00
Disclosure

SEC source: 0000921895-26-000312 · form409076051_02122026.xml · nonDerivative · entry 1

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,180,000

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F3 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $6.1500 to $6.3700, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
December 09, 2025 Filed Dec 11, 2025 22:53 UTC HARTE HANKS INC HHS · Entity 7438 GrantCommon Stock 27,861 $3.23 $89,991.03
Disclosure

SEC source: 0001628280-25-056611 · wk-form4_1765493594.xml · nonDerivative · entry 1

Radoff Bradley Louis · CIK 0001380585 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · RSU shares held by Harte Hanks, granted to the participant but not yet vested

Disclosed balance after: 27,861

F1 · balance_after: Participant was granted 27,861 RSU shares on 12/09/2025 that will vest 100% on the first anniversary of the grant date.

Read SEC document
November 14, 2025 Filed Nov 17, 2025 21:20 UTC KVH INDUSTRIES INC \DE\ KVHI · Entity 6612 PurchaseCommon Stock 40,000 $5.78 $231,180.00
Disclosure

SEC source: 0000921895-25-003148 · form409076051_11172025.xml · nonDerivative · entry 1

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,150,000

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F3 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $5.4400 to $5.9400, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
August 20, 2025 Filed Aug 20, 2025 08:31 UTC ENZO BIOCHEM INC ENZB · Entity 76314 Disposition to issuerCommon Stock 430,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-25-078744 · ownership.xml · nonDerivative · entry 2

Radoff Bradley Louis · CIK 0001380585 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Radoff Family Foundation

Disclosed balance after: 0

F1 · shares: The shares were disposed of pursuant to the Agreement and Plan of Merger, dated June 23, 2025 (the "Merger Agreement"), by and among the Issuer, Bethpage Parent, Inc. ("Parent"), and Bethpage Merger Sub, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"). Pursuant to the terms of the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly-owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of the Issuer's common stock, par value $0.01 per share ("Common Stock"), was canceled and automatically converted into the right to receive $0.70 in cash, without interest and less any applicable withholding taxes (the "Merger Consideration").

F1 · price: The shares were disposed of pursuant to the Agreement and Plan of Merger, dated June 23, 2025 (the "Merger Agreement"), by and among the Issuer, Bethpage Parent, Inc. ("Parent"), and Bethpage Merger Sub, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"). Pursuant to the terms of the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly-owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of the Issuer's common stock, par value $0.01 per share ("Common Stock"), was canceled and automatically converted into the right to receive $0.70 in cash, without interest and less any applicable withholding taxes (the "Merger Consideration").

Read SEC document
August 20, 2025 Filed Aug 20, 2025 08:31 UTC ENZO BIOCHEM INC ENZB · Entity 76314 Disposition to issuerCommon Stock 4,533,779 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-25-078744 · ownership.xml · nonDerivative · entry 1

Radoff Bradley Louis · CIK 0001380585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · shares: The shares were disposed of pursuant to the Agreement and Plan of Merger, dated June 23, 2025 (the "Merger Agreement"), by and among the Issuer, Bethpage Parent, Inc. ("Parent"), and Bethpage Merger Sub, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"). Pursuant to the terms of the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly-owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of the Issuer's common stock, par value $0.01 per share ("Common Stock"), was canceled and automatically converted into the right to receive $0.70 in cash, without interest and less any applicable withholding taxes (the "Merger Consideration").

F2 · shares: Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit ("RSU") that vested solely on the basis of time that was outstanding as of immediately prior to the Effective Time and was held by a member of the Issuer's Board of Directors was canceled and converted into the right to receive an amount in cash obtained by multiplying (A) the total number of shares of Common Stock underlying such RSU, by (B) the Merger Consideration, subject to any required withholding of taxes.

F3 · shares: Represents 142,897 RSUs and 4,390,882 shares of Common Stock.

F1 · price: The shares were disposed of pursuant to the Agreement and Plan of Merger, dated June 23, 2025 (the "Merger Agreement"), by and among the Issuer, Bethpage Parent, Inc. ("Parent"), and Bethpage Merger Sub, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"). Pursuant to the terms of the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly-owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of the Issuer's common stock, par value $0.01 per share ("Common Stock"), was canceled and automatically converted into the right to receive $0.70 in cash, without interest and less any applicable withholding taxes (the "Merger Consideration").

F2 · price: Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit ("RSU") that vested solely on the basis of time that was outstanding as of immediately prior to the Effective Time and was held by a member of the Issuer's Board of Directors was canceled and converted into the right to receive an amount in cash obtained by multiplying (A) the total number of shares of Common Stock underlying such RSU, by (B) the Merger Consideration, subject to any required withholding of taxes.

Read SEC document
May 23, 2025 Filed May 28, 2025 23:16 UTC HARTE HANKS INC HHS · Entity 7438 OtherCommon Stock 12,048 $4.56 $54,900.33
Disclosure

SEC source: 0000921895-25-001632 · form409076rad_05282025.xml · nonDerivative · entry 2

Radoff Bradley Louis · CIK 0001380585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 403,447

F1 · kind: RSU shares vested and converted from indirect owned non-derivatives to direct owned non-derivative shares.

Read SEC document
May 23, 2025 Filed May 28, 2025 23:16 UTC HARTE HANKS INC HHS · Entity 7438 OtherCommon Stock 12,048 $4.56 $54,900.33
Disclosure

SEC source: 0000921895-25-001632 · form409076rad_05282025.xml · nonDerivative · entry 1

Radoff Bradley Louis · CIK 0001380585 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · RSU shares held by Harte Hanks, granted to the participant but not yet vested

Disclosed balance after: 0

F1 · kind: RSU shares vested and converted from indirect owned non-derivatives to direct owned non-derivative shares.

F2 · balance_after: Participant was granted 12,048 RSU shares on 5/23/2024 that vested 100% on the first anniversary of the grant date.

Read SEC document
February 07, 2025 Filed Feb 11, 2025 21:26 UTC FARMER BROTHERS CO FARM · Entity 49843 GrantCommon Stock 38,000 $0.00 $0.00
Disclosure

SEC source: 0000034563-25-000030 · wk-form4_1739309164.xml · nonDerivative · entry 1

Radoff Bradley Louis · CIK 0001380585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 368,679

F1 · kind: Grant of restricted stock units ("RSUs") under the Farmer Bros. Co. 2017 Long-Term Incentive Plan ("Plan") granted on February 7, 2025 ("Grant Date"). Subject to the provisions of the Plan and the RSU grant agreement, the RSUs shall vest 100% on the earlier of: (i) the one year anniversary of the Grant Date or (ii) the date of the first annual meeting of the Company's stockholders immediately following the Grant Date.

Read SEC document
January 16, 2025 Filed Jan 17, 2025 16:44 UTC ENZO BIOCHEM INC ENZ · Entity 76314 GrantCommon Stock 142,897 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-004656 · ownership.xml · nonDerivative · entry 1

Radoff Bradley Louis · CIK 0001380585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,533,779

F1 · shares: The Reporting Person was granted Restricted Stock Units that will fully vest upon the earlier of: (i) the first anniversary of the grant date (i.e., January 16, 2026), or (ii) a change of control event.

Read SEC document
December 05, 2024 Filed Dec 6, 2024 21:45 UTC HARTE HANKS INC HHS · Entity 7438 PurchaseCommon Stock 1,084 $5.90 $6,395.60
Disclosure

SEC source: 0000045919-24-000093 · wk-form4_1733521546.xml · nonDerivative · entry 19

Radoff Bradley Louis · CIK 0001380585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 391,399

F1 · shares: Participant purchased common shares.

Read SEC document
December 05, 2024 Filed Dec 6, 2024 21:45 UTC HARTE HANKS INC HHS · Entity 7438 PurchaseCommon Stock 327 $5.89 $1,926.03
Disclosure

SEC source: 0000045919-24-000093 · wk-form4_1733521546.xml · nonDerivative · entry 18

Radoff Bradley Louis · CIK 0001380585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 390,315

F1 · shares: Participant purchased common shares.

Read SEC document
December 05, 2024 Filed Dec 6, 2024 21:45 UTC HARTE HANKS INC HHS · Entity 7438 PurchaseCommon Stock 117 $5.89 $689.13
Disclosure

SEC source: 0000045919-24-000093 · wk-form4_1733521546.xml · nonDerivative · entry 17

Radoff Bradley Louis · CIK 0001380585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 389,988

F1 · shares: Participant purchased common shares.

Read SEC document
December 05, 2024 Filed Dec 6, 2024 21:45 UTC HARTE HANKS INC HHS · Entity 7438 PurchaseCommon Stock 99 $5.88 $582.12
Disclosure

SEC source: 0000045919-24-000093 · wk-form4_1733521546.xml · nonDerivative · entry 16

Radoff Bradley Louis · CIK 0001380585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 389,871

F1 · shares: Participant purchased common shares.

Read SEC document
December 05, 2024 Filed Dec 6, 2024 21:45 UTC HARTE HANKS INC HHS · Entity 7438 PurchaseCommon Stock 219 $5.88 $1,287.72
Disclosure

SEC source: 0000045919-24-000093 · wk-form4_1733521546.xml · nonDerivative · entry 15

Radoff Bradley Louis · CIK 0001380585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 389,772

F1 · shares: Participant purchased common shares.

Read SEC document
December 05, 2024 Filed Dec 6, 2024 21:45 UTC HARTE HANKS INC HHS · Entity 7438 PurchaseCommon Stock 84 $5.87 $493.08
Disclosure

SEC source: 0000045919-24-000093 · wk-form4_1733521546.xml · nonDerivative · entry 14

Radoff Bradley Louis · CIK 0001380585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 389,553

F1 · shares: Participant purchased common shares.

Read SEC document
December 05, 2024 Filed Dec 6, 2024 21:45 UTC HARTE HANKS INC HHS · Entity 7438 PurchaseCommon Stock 1,603 $5.86 $9,393.58
Disclosure

SEC source: 0000045919-24-000093 · wk-form4_1733521546.xml · nonDerivative · entry 13

Radoff Bradley Louis · CIK 0001380585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 389,469

F1 · shares: Participant purchased common shares.

Read SEC document
December 05, 2024 Filed Dec 6, 2024 21:45 UTC HARTE HANKS INC HHS · Entity 7438 PurchaseCommon Stock 3,997 $5.85 $23,382.45
Disclosure

SEC source: 0000045919-24-000093 · wk-form4_1733521546.xml · nonDerivative · entry 12

Radoff Bradley Louis · CIK 0001380585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 387,866

F1 · shares: Participant purchased common shares.

Read SEC document
December 05, 2024 Filed Dec 6, 2024 21:45 UTC HARTE HANKS INC HHS · Entity 7438 PurchaseCommon Stock 100 $5.85 $585.00
Disclosure

SEC source: 0000045919-24-000093 · wk-form4_1733521546.xml · nonDerivative · entry 11

Radoff Bradley Louis · CIK 0001380585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 383,869

F1 · shares: Participant purchased common shares.

Read SEC document
December 05, 2024 Filed Dec 6, 2024 21:45 UTC HARTE HANKS INC HHS · Entity 7438 PurchaseCommon Stock 627 $5.84 $3,661.68
Disclosure

SEC source: 0000045919-24-000093 · wk-form4_1733521546.xml · nonDerivative · entry 10

Radoff Bradley Louis · CIK 0001380585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 383,769

F1 · shares: Participant purchased common shares.

Read SEC document
December 05, 2024 Filed Dec 6, 2024 21:45 UTC HARTE HANKS INC HHS · Entity 7438 PurchaseCommon Stock 200 $5.84 $1,168.00
Disclosure

SEC source: 0000045919-24-000093 · wk-form4_1733521546.xml · nonDerivative · entry 9

Radoff Bradley Louis · CIK 0001380585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 383,142

F1 · shares: Participant purchased common shares.

Read SEC document
December 05, 2024 Filed Dec 6, 2024 21:45 UTC HARTE HANKS INC HHS · Entity 7438 PurchaseCommon Stock 368 $5.83 $2,145.44
Disclosure

SEC source: 0000045919-24-000093 · wk-form4_1733521546.xml · nonDerivative · entry 8

Radoff Bradley Louis · CIK 0001380585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 382,942

F1 · shares: Participant purchased common shares.

Read SEC document
December 05, 2024 Filed Dec 6, 2024 21:45 UTC HARTE HANKS INC HHS · Entity 7438 PurchaseCommon Stock 1,594 $5.82 $9,277.08
Disclosure

SEC source: 0000045919-24-000093 · wk-form4_1733521546.xml · nonDerivative · entry 7

Radoff Bradley Louis · CIK 0001380585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 382,574

F1 · shares: Participant purchased common shares.

Read SEC document
December 05, 2024 Filed Dec 6, 2024 21:45 UTC HARTE HANKS INC HHS · Entity 7438 PurchaseCommon Stock 200 $5.81 $1,162.00
Disclosure

SEC source: 0000045919-24-000093 · wk-form4_1733521546.xml · nonDerivative · entry 6

Radoff Bradley Louis · CIK 0001380585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 380,980

F1 · shares: Participant purchased common shares.

Read SEC document
December 05, 2024 Filed Dec 6, 2024 21:45 UTC HARTE HANKS INC HHS · Entity 7438 PurchaseCommon Stock 3,306 $5.80 $19,174.80
Disclosure

SEC source: 0000045919-24-000093 · wk-form4_1733521546.xml · nonDerivative · entry 5

Radoff Bradley Louis · CIK 0001380585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 380,780

F1 · shares: Participant purchased common shares.

Read SEC document
December 05, 2024 Filed Dec 6, 2024 21:45 UTC HARTE HANKS INC HHS · Entity 7438 PurchaseCommon Stock 2,853 $5.78 $16,490.34
Disclosure

SEC source: 0000045919-24-000093 · wk-form4_1733521546.xml · nonDerivative · entry 4

Radoff Bradley Louis · CIK 0001380585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 377,474

F1 · shares: Participant purchased common shares.

Read SEC document
December 05, 2024 Filed Dec 6, 2024 21:45 UTC HARTE HANKS INC HHS · Entity 7438 PurchaseCommon Stock 245 $5.77 $1,413.65
Disclosure

SEC source: 0000045919-24-000093 · wk-form4_1733521546.xml · nonDerivative · entry 3

Radoff Bradley Louis · CIK 0001380585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 374,621

F1 · shares: Participant purchased common shares.

Read SEC document
December 05, 2024 Filed Dec 6, 2024 21:45 UTC HARTE HANKS INC HHS · Entity 7438 PurchaseCommon Stock 2 $5.76 $11.52
Disclosure

SEC source: 0000045919-24-000093 · wk-form4_1733521546.xml · nonDerivative · entry 2

Radoff Bradley Louis · CIK 0001380585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 374,376

F1 · shares: Participant purchased common shares.

Read SEC document
December 05, 2024 Filed Dec 6, 2024 21:45 UTC HARTE HANKS INC HHS · Entity 7438 PurchaseCommon Stock 200 $5.75 $1,150.00
Disclosure

SEC source: 0000045919-24-000093 · wk-form4_1733521546.xml · nonDerivative · entry 1

Radoff Bradley Louis · CIK 0001380585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 374,374

F1 · shares: Participant purchased common shares.

Read SEC document
December 04, 2024 Filed Dec 5, 2024 23:07 UTC HARTE HANKS INC HHS · Entity 7438 PurchaseCommon Stock 2,824 $5.70 $16,096.80
Disclosure

SEC source: 0000045919-24-000091 · wk-form4_1733440042.xml · nonDerivative · entry 22

Radoff Bradley Louis · CIK 0001380585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 374,174

F1 · shares: Participant purchased common shares.

Read SEC document
December 04, 2024 Filed Dec 5, 2024 23:07 UTC HARTE HANKS INC HHS · Entity 7438 PurchaseCommon Stock 590 $5.69 $3,357.10
Disclosure

SEC source: 0000045919-24-000091 · wk-form4_1733440042.xml · nonDerivative · entry 21

Radoff Bradley Louis · CIK 0001380585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 371,350

F1 · shares: Participant purchased common shares.

Read SEC document
December 04, 2024 Filed Dec 5, 2024 23:07 UTC HARTE HANKS INC HHS · Entity 7438 PurchaseCommon Stock 774 $5.68 $4,396.32
Disclosure

SEC source: 0000045919-24-000091 · wk-form4_1733440042.xml · nonDerivative · entry 20

Radoff Bradley Louis · CIK 0001380585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 370,760

F1 · shares: Participant purchased common shares.

Read SEC document
December 04, 2024 Filed Dec 5, 2024 23:07 UTC HARTE HANKS INC HHS · Entity 7438 PurchaseCommon Stock 100 $5.68 $568.00
Disclosure

SEC source: 0000045919-24-000091 · wk-form4_1733440042.xml · nonDerivative · entry 19

Radoff Bradley Louis · CIK 0001380585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 369,986

F1 · shares: Participant purchased common shares.

Read SEC document
December 04, 2024 Filed Dec 5, 2024 23:07 UTC HARTE HANKS INC HHS · Entity 7438 PurchaseCommon Stock 100 $5.67 $567.00
Disclosure

SEC source: 0000045919-24-000091 · wk-form4_1733440042.xml · nonDerivative · entry 18

Radoff Bradley Louis · CIK 0001380585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 369,886

F1 · shares: Participant purchased common shares.

Read SEC document
December 04, 2024 Filed Dec 5, 2024 23:07 UTC HARTE HANKS INC HHS · Entity 7438 PurchaseCommon Stock 16,800 $5.66 $95,088.00
Disclosure

SEC source: 0000045919-24-000091 · wk-form4_1733440042.xml · nonDerivative · entry 17

Radoff Bradley Louis · CIK 0001380585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 369,786

F1 · shares: Participant purchased common shares.

Read SEC document
December 04, 2024 Filed Dec 5, 2024 23:07 UTC HARTE HANKS INC HHS · Entity 7438 PurchaseCommon Stock 100 $5.66 $566.00
Disclosure

SEC source: 0000045919-24-000091 · wk-form4_1733440042.xml · nonDerivative · entry 16

Radoff Bradley Louis · CIK 0001380585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 352,986

F1 · shares: Participant purchased common shares.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.